3 March 2021
Latham & Watkins Advises Boston Scientific in US$1.07 Billion Acquisition of Lumenis LTD. Surgical Business
Advising firms
Deal team
25 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Julie Scallen Lead | Latham & Watkins LLP | Partner | corporate | Boston |
| Hans Brigham | Latham & Watkins LLP | Partner | corporate | Boston |
| Cory Lewis | Latham & Watkins LLP | Associate | corporate | Boston |
| Dante Spurlock | Latham & Watkins LLP | Associate | corporate | Boston |
| Michael Casagrande | Latham & Watkins LLP | Associate | corporate | Boston |
| Nicholas DeNovio | Latham & Watkins LLP | Partner | tax | Washington, D.C. |
| Pierce Pandolph | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| Drew Levin | Latham & Watkins LLP | Partner | insurance | Los Angeles |
| Hannah Cary | Latham & Watkins LLP | Associate | insurance | San Diego |
| Robin Struve | Latham & Watkins LLP | Partner | benefits and compensation | Chicago |
| Leah Segall | Latham & Watkins LLP | Associate | benefits and compensation | Chicago |
| Victoria Wolfe | Latham & Watkins LLP | Associate | benefits and compensation | Chicago |
| Andrea Schwartzman | Latham & Watkins LLP | Partner | investment funds | New York |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | regulatory | Bay Area |
| Lacey Henry | Latham & Watkins LLP | Associate | regulatory | New York |
| Alyssa Lattner | Latham & Watkins LLP | Associate | regulatory | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Counsel | data privacy | Bay Area |
| Mihail Krepchev | Latham & Watkins LLP | Associate | data privacy | London |
| Katherine Sawyer | Latham & Watkins LLP | Counsel | compliance | Los Angeles |
| Elizabeth Annis | Latham & Watkins LLP | Associate | compliance | Washington, D.C. |
| James Barrett | Latham & Watkins LLP | Partner | environmental | Washington, D.C. |
| Shlomo Fellig | Latham & Watkins LLP | Associate | litigation | Boston |
| Rowland Cheng | Latham & Watkins LLP | Partner | China-related | Shanghai |
| Vincent Jiang | Latham & Watkins LLP | Associate | China-related | Shanghai |
Stated terms
- Stated value
- USD 1.07bn (US$1.07 billion)
- What the figure measures
- Total transaction value
- Client
- Boston ScientificBuy-side
- Counterparties
- Baring Private Equity Asia (Sell-side)
Lumenis LTD. (Target)